Soleno Therapeutics Inc.

NASDAQ: SLNO · Real-Time Price · USD
71.63
-5.73 (-7.41%)
At close: Aug 15, 2025, 3:59 PM
72.00
0.52%
After-hours: Aug 15, 2025, 07:57 PM EDT

Soleno Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
76.5M 81.33M 87.93M 48.41M 57.02M 42.85M 169.68M 52.44M 19.37M 7.87M 14.6M 19.75M 24.07M 28.97M 21.3M 28.18M 33.6M 41.61M
Short-Term Investments
210.34M 208.62M 203.51M 208.36M 209.1M 106.78M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
7M n/a 27.21M 27.95M 28.48M 8.82M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
83K 83K 83K 83K 83K 165K 165K 165K 165K 126K n/a n/a n/a 40K 40K 40K 40K n/a
Receivables
24.62M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
2.35M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
2.97M 18.96M 2.45M 1.42M 1.38M 1.6M 1.68M 1.22M 1.13M 1.25M 1.04M 821K 824K 1M 1.12M 702K 948K 921K
Total Current Assets
316.79M 308.92M 293.89M 258.2M 267.5M 151.22M 171.36M 53.66M 20.5M 9.13M 15.65M 20.57M 24.89M 29.98M 22.42M 28.89M 34.54M 42.53M
Property-Plant & Equipment
2.6M 2.78M 2.98M 3.19M 287K 365K 419K 489K 560K 75K 157K 229K 307K 377K 454K 515K 585K 83K
Goodwill & Intangibles
5.83M 6.32M 6.8M 7.29M 7.78M 8.26M 8.75M 9.23M 9.72M 10.21M 10.69M 11.18M 11.66M 12.15M 12.64M 13.12M 13.61M 14.1M
Total Long-Term Assets
15.52M 9.18M 37.08M 38.51M 36.63M 17.61M 9.33M 9.89M 10.45M 10.41M 10.85M 11.41M 11.97M 12.57M 13.13M 13.68M 14.23M 14.18M
Total Assets
332.31M 318.09M 330.97M 296.71M 304.13M 168.84M 180.69M 63.55M 30.94M 19.54M 26.5M 31.98M 36.86M 42.55M 35.55M 42.56M 48.78M 56.71M
Account Payables
6.22M 5.48M 8.88M 6.24M 3.72M 8.02M 3.15M 3.22M 3.44M 2.78M 1.78M 2.32M 2.41M 2.41M 3.25M 3.86M 3.35M 4.67M
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a 4.74M 4.63M n/a n/a n/a n/a n/a 4.15M 4.4M 4.58M 4.55M
Short-Term Debt
n/a n/a n/a n/a 296K n/a 273K 256K 212K n/a n/a 239K 337K 344K n/a 290K 180K 57K
Other Current Liabilities
11.78M 7.4M 7.51M 6.51M 2.98M 1.51M 4.67M 22.03M 1.47M 692K 484K 3.26M 3.23M 3.62M 3.74M 1.01M 727K 586K
Total Current Liabilities
20.94M 15.73M 18.75M 14.96M 9.15M 13.46M 11.51M 28.99M 8.8M 7.76M 7.31M 7.34M 7.25M 7.31M 8.01M 9.04M 8.36M 9.51M
Long-Term Debt
49.84M 49.84M 49.83M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
19.13M 17.9M 14.81M 14.46M 14.22M 11.95M 11.55M 11.12M 9.45M 9.13M 8.84M 9.44M 9.31M 8.69M 9.58M 13.05M 12.61M 9.63M
Total Long-Term Liabilities
71.22M 70.1M 67.11M 17.05M 14.22M 11.99M 11.68M 11.34M 9.72M 9.13M 8.84M 9.44M 9.31M 8.77M 9.75M 13.32M 12.98M 9.63M
Total Liabilities
92.17M 85.83M 85.86M 32.01M 23.37M 25.45M 23.18M 40.33M 18.52M 16.9M 16.15M 16.78M 16.55M 16.09M 17.76M 22.36M 21.34M 19.14M
Total Debt
52.77M 52.79M 52.83M 3.03M 296K 347K 403K 470K 485K 39K 155K 239K 337K 423K 457K 564K 552K 57K
Common Stock
50K 49K 46K 41K 38K 33K 32K 15K 10K 8K 8K 8K 120K 120K 80K 80K 80K 80K
Retained Earnings
-500.74M -496.03M -452.26M -396.28M -319.66M -297.81M -276.41M -265.11M -254.25M -245.78M -237.42M -231.94M -225.8M -219.08M -213.35M -210.53M -202.39M -191.4M
Comprehensive Income
85K 226K 361K n/a -153K -106K 0.00 -1K n/a 16K n/a -2K -1K -2K -0.00 -0.00 n/a n/a
Shareholders Equity
240.14M 232.26M 245.11M 264.7M 280.76M 143.39M 157.51M 23.22M 12.43M 2.64M 10.35M 15.2M 20.31M 26.46M 17.79M 20.2M 27.44M 37.57M
Total Investments
217.35M 208.62M 230.72M 236.31M 237.58M 115.6M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a